Changing the treatment paradigm for type 2 diabetes.
Del Prato
Stefano
S
Department of Endocrinology and Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy. delprato@immr.med.unipi.it
Penno
Giuseppe
G
Miccoli
Roberto
R
D000465:Algorithms; D001786:Blood Glucose / Q000378:metabolism*; D003695:Delivery of Health Care / Q000592:standards; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control / Q000628:therapy; D015444:Exercise; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use; D010353:Patient Education as Topic; D040242:Risk Reduction Behavior
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008687:Metformin